Why the study?
Balancing efficacious and clinically safe anticoagulation is challenging in older patients with conditions like atrial fibrillation who face heightened risks of both thrombosis and bleeding.
Highlights the clinical necessity and safety considerations, particularly major bleeding risk, of anticoagulant use in older patients.
No takes yet. Share an insight, caveat, or question.
Balancing thrombosis and bleeding risks in elderly AF patients remains challenging; leaves open optimal lifelong strategies for this high-risk group.
Sallis et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: